225 related articles for article (PubMed ID: 11717191)
1. xid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B cell development.
Cancro MP; Sah AP; Levy SL; Allman DM; Schmidt MR; Woodland RT
Int Immunol; 2001 Dec; 13(12):1501-14. PubMed ID: 11717191
[TBL] [Abstract][Full Text] [Related]
2. B cell production and turnover in CBA/Ca, CBA/N and CBA/N-bcl-2 transgenic mice: xid-mediated failure among pre B cells is unaltered by bcl-2 overexpression.
Cancro MP; Sah AP; Levy SL; Allman DM; Constantinescu D; Schmidt MR; Woodland RT
Curr Top Microbiol Immunol; 2000; 252():31-8. PubMed ID: 11125490
[TBL] [Abstract][Full Text] [Related]
3. A re-evaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse.
Klaus GG; Holman M; Johnson-Léger C; Elgueta-Karstegl C; Atkins C
Eur J Immunol; 1997 Nov; 27(11):2749-56. PubMed ID: 9394795
[TBL] [Abstract][Full Text] [Related]
4. Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing.
Middendorp S; Hendriks RW
J Immunol; 2004 Feb; 172(3):1371-9. PubMed ID: 14734712
[TBL] [Abstract][Full Text] [Related]
5. Regulation of B cell survival in xid mice by the proto-oncogene bcl-2.
Woodland RT; Schmidt MR; Korsmeyer SJ; Gravel KA
J Immunol; 1996 Mar; 156(6):2143-54. PubMed ID: 8690903
[TBL] [Abstract][Full Text] [Related]
6. Early arrest in B cell development in transgenic mice that express the E41K Bruton's tyrosine kinase mutant under the control of the CD19 promoter region.
Maas A; Dingjan GM; Grosveld F; Hendriks RW
J Immunol; 1999 Jun; 162(11):6526-33. PubMed ID: 10352268
[TBL] [Abstract][Full Text] [Related]
7. Impaired precursor B cell differentiation in Bruton's tyrosine kinase-deficient mice.
Middendorp S; Dingjan GM; Hendriks RW
J Immunol; 2002 Mar; 168(6):2695-703. PubMed ID: 11884435
[TBL] [Abstract][Full Text] [Related]
8. Naive B lymphocytes undergo homeostatic proliferation in response to B cell deficit.
Cabatingan MS; Schmidt MR; Sen R; Woodland RT
J Immunol; 2002 Dec; 169(12):6795-805. PubMed ID: 12471111
[TBL] [Abstract][Full Text] [Related]
9. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice.
Rawlings DJ; Saffran DC; Tsukada S; Largaespada DA; Grimaldi JC; Cohen L; Mohr RN; Bazan JF; Howard M; Copeland NG
Science; 1993 Jul; 261(5119):358-61. PubMed ID: 8332901
[TBL] [Abstract][Full Text] [Related]
10. An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.
Anderson JS; Teutsch M; Dong Z; Wortis HH
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10966-71. PubMed ID: 8855292
[TBL] [Abstract][Full Text] [Related]
11. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.
Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE
Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
[TBL] [Abstract][Full Text] [Related]
13. B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation.
Clarke SH; Arnold LW
J Exp Med; 1998 Apr; 187(8):1325-34. PubMed ID: 9547343
[TBL] [Abstract][Full Text] [Related]
14. Accelerated emigration of B lymphocytes in the Xid mouse.
Cariappa A; Kim TJ; Pillai S
J Immunol; 1999 Apr; 162(8):4417-23. PubMed ID: 10201977
[TBL] [Abstract][Full Text] [Related]
15. Posttranscriptional regulation of Bruton's tyrosine kinase expression in antigen receptor-stimulated splenic B cells.
Nisitani S; Satterthwaite AB; Akashi K; Weissman IL; Witte ON; Wahl MI
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2737-42. PubMed ID: 10688914
[TBL] [Abstract][Full Text] [Related]
16. Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.
Dingjan GM; Maas A; Nawijn MC; Smit L; Voerman JS; Grosveld F; Hendriks RW
EMBO J; 1998 Sep; 17(18):5309-20. PubMed ID: 9736610
[TBL] [Abstract][Full Text] [Related]
17. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction.
Santos-Argumedo L; Lund FE; Heath AW; Solvason N; Wu WW; Grimaldi JC; Parkhouse RM; Howard M
Int Immunol; 1995 Feb; 7(2):163-70. PubMed ID: 7734414
[TBL] [Abstract][Full Text] [Related]
18. bcl-2 alters the antigen-driven selection of B cells in mukappa but not in mu-only Xid transgenic mice.
Kenny JJ; Fischer RT; Lustig A; Dintzis H; Katsumata M; Reed JC; Longo DL
J Immunol; 1996 Aug; 157(3):1054-61. PubMed ID: 8757609
[TBL] [Abstract][Full Text] [Related]
19. Tracking the response of Xid B cells in vivo: TI-2 antigen induces migration and proliferation but Btk is essential for terminal differentiation.
Vinuesa CG; Sunners Y; Pongracz J; Ball J; Toellner KM; Taylor D; MacLennan IC; Cook MC
Eur J Immunol; 2001 May; 31(5):1340-50. PubMed ID: 11465091
[TBL] [Abstract][Full Text] [Related]
20. xid affects events leading to B cell cycle entry.
Brorson K; Brunswick M; Ezhevsky S; Wei DG; Berg R; Scott D; Stein KE
J Immunol; 1997 Jul; 159(1):135-43. PubMed ID: 9200448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
